Boston-based device maker NMT Medical Inc. has received a two-year line of credit worth $4 million from Silicon Valley Bank. The loan will be used to help finance the company’s clinical trials and development programs, NMT Medical officials said in a press release.
The extra funding also supports NMT’s treatment for structural heart disease.
NMT Medical develops implant technologies that treat structural heart disease using minimally invasive, catheter-based procedures.
The company has seen a number of personnel changes in the executive management team. Earlier this month, NMT Medical named Richard Davis, NMT chief operating officer, to the board of directors. In February, the company announced the retirement of president and CEO John Ahern, who was replaced permanently two months later by Frank Martin, who had been serving as interim president and CEO. Martin said in a statement that he plans to transition NMT’s focus on research and development to one emphasizing the sales and marketing of its BioSTAR product, a bioabsorbable septal repair implant for the heart.
Silicon Valley Bank is a subsidiary of SVB Financial Group of Santa Clara, Calif.
Latest from Today's Medical Developments
- NextDent 300 MultiJet printer delivers a “Coming of Age for Digital Dentistry” at Evolution Dental Solutions
- Get recognized for bringing manufacturing back to North America
- Adaptive Coolant Flow improves energy efficiency
- VOLTAS opens coworking space for medical device manufacturers
- MEMS accelerometer for medical implants, wearables
- The compact, complex capabilities of photochemical etching
- Moticont introduces compact, linear voice coil motor
- Manufacturing technology orders reach record high in December 2025
